Data gathered: August 2
AI Stock Analysis - Merck & Company (MRK)
Analysis generated February 14, 2025. Powered by Chat GPT.
Merck & Co., Inc. (MRK) is a global healthcare company headquartered in Kenilworth, New Jersey. The company focuses on several areas of medicine, including oncology, vaccines, infectious diseases, and animal health. Founded in 1891, Merck's mission revolves around discovering, developing, manufacturing, and marketing innovative pharmaceuticals to solve growing medical challenges.
Stock Alerts - Merck & Company (MRK)
 |
Merck & Company | July 30 Reddit mentions are up by 526% in the last 24h. |
|
Merck & Company | July 29 Price is down by -8.2% in the last 24h. |
|
Merck & Company | July 15 Scott Mr Franklin (member of U.S. congress) is selling shares |
|
Merck & Company | July 4 Scott Mr Franklin (member of U.S. congress) is buying shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Merck & Company
About Merck & Company
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, diabetes, and women's health, as well as vaccine products. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.
| Price | $79.29 |
| Target Price | Sign up |
| Volume | 11,880,000 |
| Market Cap | $196B |
| Year Range | $72.74 - $101.07 |
| Dividend Yield | 3.87% |
| PE Ratio | 12.04 |
| Analyst Rating | 59% buy |
| Industry | Drug Manufacturers |
In the news
 |
Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRMJuly 30 - Yahoo |
|
Merck (MRK) Revises 2025 Sales Guidance and Reports Lower Q2 EarningsJuly 30 - Yahoo |
|
Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...July 29 - Yahoo |
|
Why Merck (MRK) Shares Are Sliding TodayJuly 29 - Yahoo |
|
Merck (MRK) Reports Decline in Q2 Earnings & Updates 2025 Sales GuidanceJuly 29 - Yahoo |
 |
Merck & Co., Inc. (MRK) Q2 2025 Earnings Call TranscriptJuly 28 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 15.8B | 3.56B | 12.2B | 4.43B | 5B | 2.130 |
| Q1 '25 | 15.5B | 3.42B | 12.1B | 5.08B | 7.32B | 2.220 |
| Q4 '24 | 15.6B | 3.83B | 11.8B | 3.74B | 5.7B | 1.720 |
| Q3 '24 | 16.7B | 4.08B | 12.6B | 3.16B | 5.61B | 1.570 |
| Q2 '24 | 16.1B | 3.75B | 12.4B | 5.46B | 7.45B | 2.280 |
Insider Transactions View All
| Smart Dalton E. III filed to sell 7,778 shares at $82.8. April 29 '25 |
| Oosthuizen Johannes Jacobus filed to sell 30,705 shares at $84.1. February 20 '25 |
| Williams David Michael filed to sell 24,123 shares at $85.3. February 13 '25 |
| Downing Cristal N filed to sell 7,085 shares at $88.8. February 7 '25 |
| THULIN INGE G filed to buy 2,933 shares at $88.3. February 7 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$167.33 0% | 47 |
 |
Eli Lilly and CompanyLLY |
$762.33 0% | 58 |
 |
PfizerPFE |
$23.49 0% | 44 |
 |
AstrazenecaAZN |
$73.95 0% | 58 |
 |
AbbVieABBV |
$195.22 0% | 49 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
Jul 15, 25 | Buy | $1K - $15K |
| Scott Mr Franklin |
Jul 15, 25 | Sell | $1K - $15K |
| Scott Mr Franklin |
Jul 4, 25 | Buy | $1K - $15K |
Read more about Merck & Company (MRK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Merck & Company?
The Market Cap of Merck & Company is $196B.
What is Merck & Company's PE Ratio?
As of today, Merck & Company's PE (Price to Earnings) ratio is 12.04.
What is the current stock price of Merck & Company?
Currently, the price of one share of Merck & Company stock is $79.29.
How can I analyze the MRK stock price chart for investment decisions?
The MRK stock price chart above provides a comprehensive visual representation of Merck & Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Merck & Company shares. Our platform offers an up-to-date MRK stock price chart, along with technical data analysis and alternative data insights.
Does MRK offer dividends to its shareholders?
Yes, Merck & Company (MRK) offers dividends to its shareholders, with a dividend yield of 3.87%. This dividend yield represents Merck & Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Merck & Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Merck & Company?
Some of the similar stocks of Merck & Company are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.